Sameer Jamal is a Cardiology physician affiliated with Hackensack University Medical Center. OpenAlex indexes 51 publications with 626 citations (h-index 8); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Sponsor: Peerbridge Health, Inc
- Arrythmia Burden in Cardiac Contractility Modulation (CCM)
Sponsor: Hackensack Meridian Health
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Impulse DynamicsProgram year20251 paymentResearch
- Medtronic, Inc.Program year20256 payments
- Boston Scientific CorporationProgram year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
64.7%Beta blocker33.7%Metoprolol Succinate47%Metoprolol Tartrate43%Carvedilol11%Part D<11 patientsAntiarrhythmic26.7%Amiodarone Hcl49%Flecainide Acetate31%Multaq20%Part D<11 patients+ 1 more class in this area
Blood & clotting
35.3%Factor Xa inhibitor31.3%Eliquis85%Xarelto15%Part D<11 patientsDirect thrombin inhibitors4%Pradaxa100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-CCC-13234-ACC THE STABLE VENTRICULAR SEPTAL DEFECT: A CASE OF A WOLF IN SHEEP'S CLOTHING
Journal of the American College of Cardiology
2026 - 26-A-13954-ACC IMPACT OF REVASCULARIZATION STRATEGY ON NATIVE HEART SURVIVAL IN PATIENTS WITH CARDIOGENIC SHOCK SUPPORTED BY FULL LEFT VENTRICULAR UNLOADING
Journal of the American College of Cardiology
2026 - The weekend effect in atrial fibrillation hospitalizations: a nationwide analysis of outcomes and interventions
Clinical Research in Cardiology
2026 - 26-CCC-10905-ACC A LIFETIME OF SILENCE: EBSTEIN’S ANOMALY HIDING IN PLAIN SIGHT FOR EIGHT DECADES
Journal of the American College of Cardiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Stifelman, MD
Hackensack University Medical Center
Steven Ghanny, MD
Hackensack University Medical Center
Andre Goy, MD
Hackensack University Medical Center
David Vesole, MD
Hackensack University Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”